Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880331 | PMC |
| http://dx.doi.org/10.1186/s12933-024-02170-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
Cardiovasc Diabetol
February 2024
Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, UK.
Correction: Non-enzymatic heparanase enhances gastric tumor proliferation via TFEB-dependent autophagy.
Oncogenesis
August 2023
Department of Gastroenterology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China.
Correction: Heparanase promotes endothelial-to-mesenchymal transition in diabetic glomerular endothelial cells through mediating ERK signaling.
Cell Death Discov
March 2022
Department of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dongan Road, 200032, Shanghai, China.
[Corrigendum] Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells and .
Int J Oncol
March 2022
Institute of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing 400038, P.R. China.
Following the publication of this article, an interested reader drew to the authors' attention that two images in Fig. 1B (the a and d panels) appeared to represent the same clone, albeit with different intensities and the panels were cropped differently. The authors were able to confirm that Figs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!